ARCHIVES

ICCCR to Focus Its Efforts on Prevention Research

This article is from The Cancer Letter archive.

Vol. 17 No. 08 | February 22, 1991

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

June 21, 2002

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

Drug Discovery Group Announcement Issued

January 7, 1983

Groups Accepting Need for More Collaboration, NCI Backs Away From Drastic Structural Changes

July 11, 1986

DCPC Board Approves Concept for New Nutrition Grants

February 10, 1989